REAL TIME IN-VIVO RADIATION MONITOR

Information

  • Research Project
  • 6020090
  • ApplicationId
    6020090
  • Core Project Number
    R43CA083540
  • Full Project Number
    1R43CA083540-01
  • Serial Number
    83540
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1999 - 26 years ago
  • Project End Date
    3/31/2000 - 25 years ago
  • Program Officer Name
    STONE, HELEN B.
  • Budget Start Date
    9/30/1999 - 26 years ago
  • Budget End Date
    3/31/2000 - 25 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/20/1999 - 26 years ago
Organizations

REAL TIME IN-VIVO RADIATION MONITOR

To enhance the effectiveness of radiation treatment of cancerous lesions, an improved in-vivo radiation monitoring sensor is required to quantify the dose rate and the absorbed dose. Modern treatment methods focus on concentrating the output from radioactive sources onto the cancer itself to minimize total body radiation exposure. Thus, real-time monitoring of radiation dose and dose rate can be used to optimize the radiation treatment. Conventional in-vivo radiation methods are able to measure the absorbed dose, but not the dose rate. In addition, they are influenced by environmental factors, such as the temperature and directionality of the source, and require physical access. The proposed in-vivo radiation monitor is based on a low-cost, scintillating, optical fiber probe that monitors in real-time the in-vivo dose rate and the absorbed dose of radiation. The probe is cylindrical in nature and its response is not influenced by the directionality of the source. Another unique feature to the proposed radiation sensor is that it does not require an external light source or electrical connection to probe the state of the sensor, thus making the sensor completely passive. PROPOSED COMMERCIAL APPLICATIONS: The proposed in-vivo radiation monitor has the potential to provide the medical community with a low cost radiation sensor that can monitor the dose rate and absorbed dose to which tissues are exposed during internal and external irradiation. This device will enable physicians to deliver the correct dose of radiation to eliminate cancerous tumors, thus increasing the effectiveness of radiation treatments and reducing overall treatment costs.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
  • Organization Name
    INDUSTRIAL QUALITY, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    GAITHERSBURG
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20877
  • Organization District
    UNITED STATES